399 related articles for article (PubMed ID: 26198245)
1. Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome.
Legeay S; Rodier M; Fillon L; Faure S; Clere N
Nutrients; 2015 Jul; 7(7):5443-68. PubMed ID: 26198245
[TBL] [Abstract][Full Text] [Related]
2. The potential role of green tea catechins in the prevention of the metabolic syndrome - a review.
Thielecke F; Boschmann M
Phytochemistry; 2009 Jan; 70(1):11-24. PubMed ID: 19147161
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin gallate and mitochondria-A story of life and death.
Oliveira MR; Nabavi SF; Daglia M; Rastrelli L; Nabavi SM
Pharmacol Res; 2016 Feb; 104():70-85. PubMed ID: 26731017
[TBL] [Abstract][Full Text] [Related]
4. In Vitro and In Silico Studies of the Molecular Interactions of Epigallocatechin-3-
Saeki K; Hayakawa S; Nakano S; Ito S; Oishi Y; Suzuki Y; Isemura M
Molecules; 2018 May; 23(6):. PubMed ID: 29843451
[TBL] [Abstract][Full Text] [Related]
5. Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate.
Keske MA; Ng HL; Premilovac D; Rattigan S; Kim JA; Munir K; Yang P; Quon MJ
Curr Med Chem; 2015; 22(1):59-69. PubMed ID: 25312214
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying beneficial health effects of tea catechins to improve insulin resistance and endothelial dysfunction.
Kim JA
Endocr Metab Immune Disord Drug Targets; 2008 Jun; 8(2):82-8. PubMed ID: 18537694
[TBL] [Abstract][Full Text] [Related]
7. The challenge of developing green tea polyphenols as therapeutic agents.
Huo C; Wan SB; Lam WH; Li L; Wang Z; Landis-Piwowar KR; Chen D; Dou QP; Chan TH
Inflammopharmacology; 2008 Oct; 16(5):248-52. PubMed ID: 18815735
[TBL] [Abstract][Full Text] [Related]
8. Effects of green tea and EGCG on cardiovascular and metabolic health.
Wolfram S
J Am Coll Nutr; 2007 Aug; 26(4):373S-388S. PubMed ID: 17906191
[TBL] [Abstract][Full Text] [Related]
9. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
James KD; Forester SC; Lambert JD
Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
[TBL] [Abstract][Full Text] [Related]
10. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR.
Potenza MA; Marasciulo FL; Tarquinio M; Tiravanti E; Colantuono G; Federici A; Kim JA; Quon MJ; Montagnani M
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1378-87. PubMed ID: 17227956
[TBL] [Abstract][Full Text] [Related]
11. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC
Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482
[TBL] [Abstract][Full Text] [Related]
12. Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG).
Kwon OS; Han JH; Yoo HG; Chung JH; Cho KH; Eun HC; Kim KH
Phytomedicine; 2007 Aug; 14(7-8):551-5. PubMed ID: 17092697
[TBL] [Abstract][Full Text] [Related]
13. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
[TBL] [Abstract][Full Text] [Related]
14. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.
Rodriguez SK; Guo W; Liu L; Band MA; Paulson EK; Meydani M
Int J Cancer; 2006 Apr; 118(7):1635-44. PubMed ID: 16217757
[TBL] [Abstract][Full Text] [Related]
15. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases.
Benelli R; Venè R; Bisacchi D; Garbisa S; Albini A
Biol Chem; 2002 Jan; 383(1):101-5. PubMed ID: 11928805
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells.
Ahn HY; Xu Y; Davidge ST
Life Sci; 2008 Apr; 82(17-18):964-8. PubMed ID: 18397796
[TBL] [Abstract][Full Text] [Related]
17. Study on the pharmacokinetics of deoxyschizandrin and schizandrin in combination with epigallocatechin gallate, a component of green tea, in rats.
Liu Y; Zhang D; Wang Y; Zhang W; Liu X
Xenobiotica; 2018 Apr; 48(4):412-421. PubMed ID: 28471331
[TBL] [Abstract][Full Text] [Related]
18. Green tea epigallocatechin gallate binds to and inhibits respiratory complexes in swelling but not normal rat hepatic mitochondria.
Weng Z; Zhou P; Salminen WF; Yang X; Harrill AH; Cao Z; Mattes WB; Mendrick DL; Shi Q
Biochem Biophys Res Commun; 2014 Jan; 443(3):1097-104. PubMed ID: 24384371
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic beneficial effects of epigallocatechin gallate, quercetin and delphinidin on cardiovascular diseases associated with endothelial dysfunction.
Dayoub O; Andriantsitohaina R; Clere N
Cardiovasc Hematol Agents Med Chem; 2013 Dec; 11(4):249-64. PubMed ID: 24617305
[TBL] [Abstract][Full Text] [Related]
20. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery.
Yang QQ; Wei XL; Fang YP; Gan RY; Wang M; Ge YY; Zhang D; Cheng LZ; Corke H
Crit Rev Food Sci Nutr; 2020; 60(8):1243-1264. PubMed ID: 30799648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
